Balance Sheet Data

TG Therapeutics, Inc. (TGTX)

$14.7

-0.21 (-1.41%)

Year
A/P
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Total Cash 68.81140.43605.43314.76161.6867,608.861,501,692.0433,354,783.34740,858,672.1616,455,558,007.55
Total Cash (%)
Account Receivables 0.100.100.104.181.7438.66858.7419,073.79423,656.819,410,039.39
Account Receivables (%)
Inventories ----------
Inventories (%)
Accounts Payable --37.011,628.86678.1815,063.46334,581.657,431,549.36165,065,614.023,666,349,451.75
Accounts Payable (%)
Capital Expenditure -0.09-0.13-0.36-0.40-2.69-59.73-1,326.77-29,469.62-654,563.46-14,538,814.84
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.